Regulators Increase Scrutiny of Wellness and Telehealth Providers
Federal and state agencies are stepping up enforcement actions against telehealth platforms and wellness clinics, focusing on standard-of-care violations, marketing claims, and prescribing practices.
Federal agencies and state medical boards are escalating enforcement against the burgeoning wellness industry, targeting telehealth platforms, IV therapy bars, ketamine clinics, and weight-management providers. This heightened scrutiny follows the expiration of many pandemic-era telehealth prescribing flexibilities, exposing a range of compliance gaps. Regulators are focusing on standard-of-care violations, improper supervision of non-physician practitioners, unsubstantiated marketing claims targeted by the FTC, and DEA requirements for prescribing controlled substances like ketamine. For innovative health platforms, especially those using direct-to-consumer and cash-pay models, the risks include significant civil penalties, license discipline, and operational disruption. The trend signals a tougher environment for a high-growth sector. Counsel should advise clients to promptly conduct comprehensive compliance assessments of their prescribing and marketing protocols, provider licensing, data privacy practices, and corporate structures to mitigate exposure to this coordinated multi-jurisdictional oversight.